Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new accutane clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on accutane
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Status: Recruiting, Condition Summary: Brain and Central Nervous System Tumors - Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Status: Recruiting, Condition Summary: Neuroblastoma - Isotretinoin With or Without Vitamin E for Prevention of Lung Cancer
Status: Active, not recruiting, Condition Summary: Drug/Agent Toxicity by Tissue/Organ; Lung Cancer - Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Status: Completed, Condition Summary: Neuroblastoma - Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Status: Active, not recruiting, Condition Summary: Neuroblastoma - Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
Status: Recruiting, Condition Summary: Neuroblastoma - Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
Status: Active, not recruiting, Condition Summary: Neuroblastoma - Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial
Status: Completed, Condition Summary: Photoaging; Epidermal p53 Expression - Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Status: Recruiting, Condition Summary: Brain and Central Nervous System Tumors - High-Dose Cytarabine and Mitoxantrone in Treating Patients With Juvenile Myelomonocytic Leukemia Undergoing a Second Donor Stem Cell Transplant
Status: Recruiting, Condition Summary: Leukemia - Therapy for Children With Neuroblastoma
Status: Completed, Condition Summary: Neuroblastoma - Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
Status: Recruiting, Condition Summary: Cervical Cancer - Busulfan, Cyclophosphamide, Melphalan, and Donor Stem Cell Transplant in Treating Young Patients For Juvenile Myelomonocytic Leukemia
Status: Recruiting, Condition Summary: Leukemia - Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Status: Active, not recruiting, Condition Summary: Cervical Cancer; Esophageal Cancer; Head and Neck Cancer; Lung Cancer; Non-Melanomatous Skin Cancer; Penile Cancer - MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas
Status: Completed, Condition Summary: Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific - Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
Status: Completed, Condition Summary: Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Thrombocytopenia - Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
Status: Active, not recruiting, Condition Summary: Brain and Central Nervous System Tumors - Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
Status: Active, not recruiting, Condition Summary: Kidney Cancer - PXD101 and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
Status: Recruiting, Condition Summary: Unspecified Adult Solid Tumor, Protocol Specific - Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Status: Active, not recruiting, Condition Summary: Lung Cancer - Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
Status: Active, not recruiting, Condition Summary: Multiple Myeloma and Plasma Cell Neoplasm - Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
Status: Recruiting, Condition Summary: Kidney Cancer - Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Status: Active, not recruiting, Condition Summary: Head and Neck Cancer - Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
Status: Active, not recruiting, Condition Summary: Brain and Central Nervous System Tumors; Leukemia; Lymphoma; Neuroblastoma; Unspecified Childhood Solid Tumor, Protocol Specific - Isotretinoin in Preventing Skin Cancer
Status: Completed, Condition Summary: Melanoma (Skin); Non-Melanomatous Skin Cancer - High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
Status: Completed, Condition Summary: Brain and Central Nervous System Tumors - Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Status: Recruiting, Condition Summary: Neuroblastoma - Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
Status: Recruiting, Condition Summary: Neuroblastoma - Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Status: Active, not recruiting, Condition Summary: Prostate Cancer